Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,177 | 5,898 | 11,280 | 15,344 | 7,363 |
| Marketable Securities | 45 | 46 | 45 | 45 | 47 |
| Receivables | 88 | 71 | 50 | 15 | 12 |
| Inventories | 2,491 | 1,420 | 989 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 250 | 0 |
| TOTAL | $9,598 | $8,747 | $12,505 | $15,976 | $8,378 |
| Non-Current Assets | |||||
| PPE Net | 904 | 1,003 | 1,097 | 305 | 327 |
| Intangibles | 2,109 | 5,627 | 5,673 | 1,037 | 1,062 |
| Other Non-Current Assets | 177 | 109 | 109 | 9 | 15 |
| TOTAL | $3,190 | $6,739 | $6,879 | $1,351 | $1,403 |
| Total Assets | $12,788 | $15,486 | $19,384 | $17,327 | $9,781 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 29 | 59 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,415 | 2,867 | 3,359 | 1,845 | 2,135 |
| Other current liabilities | 500 | 801 | 801 | N/A | N/A |
| TOTAL | $3,320 | $4,106 | $4,618 | $1,927 | $2,215 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 9 | 8 | N/A | N/A |
| TOTAL | $390 | $494 | $599 | $179 | $189 |
| Total Liabilities | $3,709 | $4,599 | $5,216 | $2,106 | $2,405 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45 | 29 | 28 | 28 | 19 |
| Common Shares | 70,719 | 69,825 | 69,097 | 63,687 | 60,587 |
| Retained earnings | -93,453 | -85,583 | -82,107 | -77,824 | -74,853 |
| Other shareholders' equity | 129 | 129 | 129 | 129 | 129 |
| TOTAL | $9,079 | $10,887 | $14,167 | $15,222 | $7,377 |
| Total Liabilities And Equity | $12,788 | $15,486 | $19,384 | $17,327 | $9,781 |